The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Age-dependent decline of neprilysin in Alzheimer's disease and normal brain: Inverse correlation with Aβ levels
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291
Phases of Aβ-deposition in the human brain and its relevance for the development of AD
Thal, D. R., Rüb, U., Orantes, M., & Braak, H. (2002) · Neurology · doi:10.1212/wnl.58.12.1791 · Cited by 3,490
Gene regulation and DNA damage in the ageing human brain
Lu, T., Pan, Y., Kao, S.-Y., Li, C., Kohane, I., Chan, J., & Yankner, B. A. (2004) · Nature · doi:10.1038/nature02661 · Cited by 1,874
Correlation Between Elevated Levels of Amyloid β-Peptide in the Brain and Cognitive Decline
Näslund, J. (2000) · JAMA · doi:10.1001/jama.283.12.1571 · Cited by 1,268
Adult mouse astrocytes degrade amyloid-β in vitro and in situ
Wyss-Coray, T., Loike, J. D., Brionne, T. C., Lu, E., Anankov, R., Yan, F., Silverstein, S. C., & Husemann, J. (2003) · Nature Medicine · doi:10.1038/nm838 · Cited by 909
Davies, P., Katzman, R., & Terry, R. D. (1980) · Nature · doi:10.1038/288279a0 · Cited by 882
Age- and region-dependent alterations in Aβ-degrading enzymes: implications for Aβ-induced disorders
Caccamo, A., Oddo, S., Sugarman, M. C., Akbari, Y., & LaFerla, F. M. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.06.013 · Cited by 299
β-Secretase Activity Increases with Aging in Human, Monkey, and Mouse Brain
Fukumoto, H., Rosene, D. L., Moss, M. B., Raju, S., Hyman, B. T., & Irizarry, M. C. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63159-8 · Cited by 294
Fukami, S., Watanabe, K., Iwata, N., Haraoka, J., Lu, B., Gerard, N. P., Gerard, C., Fraser, P., Westaway, D., George-Hyslop, P. S., et al. (2002) · Neuroscience Research · doi:10.1016/s0168-0102(02)00015-9 · Cited by 157
Research works printed but not linked: 52
- Apelt, 2003, Aging-related down-regulation of neprilysin, a putative b-amyloid-degrading enzyme, in transgenic Tg2576 Alzheimer-like mouse brain is accompanied by astroglial upregulation in the vicinity of b-amyloid plaques, Neurosci. Lett., 339, 183, 10.1016/S0304-3940(03)00030-2 · DOI · Paper page
- Akiyama, 2001, Immunohistochemical localization of neprilysin in the human cerebral cortex: inverse association with vulnerability to amyloid β-protein (Aβ) deposition, Brain Res., 902, 277, 10.1016/S0006-8993(01)02390-3 · DOI
- Carpentier, 2002, Declining expression of neprilysin in Alzheimer disease vasculature: possible involvement in cerebral amyloid angiopathy, J. Neuropathol. Exp. Neurol., 6, 849, 10.1093/jnen/61.10.849 · DOI
- Carson, 2001, Beta-amyloid catabolism: roles for neprilysin (NEP) and other metallopeptidases?, J. Neurochem., 81, 1, 10.1046/j.1471-4159.2002.00855.x · DOI · Paper page
- Cleary, 2005, Natural oligomers of the amyloid-β protein specifically disrupt cognitive function, Nat. Neurosci., 8, 79, 10.1038/nn1372 · DOI · Paper page
- Eckman, 2005, Aβ-degrading enzymes: modulators of Alzheimer's disease pathogenesis and targets for therapeutic intervention, Biochem. Soc. Trans., 33, 1101, 10.1042/BST0331101 · doi:10.1042/bst0331101 · Paper page
- Evin, 2002, Biogenesis and metabolism of Alzheimer's disease Aβ amyloid peptides, Peptides, 23, 1285, 10.1016/S0196-9781(02)00063-3 · DOI · Paper page
- Funato, 1998, Quantitation of amyloid β-protein (Aβ) in the cortex during aging and in Alzheimer's disease, Am. J. Pathol., 152, 1633
- Guan, 2002, Selective changes in the levels of nicotinic acetylcholine receptor protein and of corresponding mRNA species in the brains of patients with Parkinson's disease, Brain Res., 956, 358, 10.1016/S0006-8993(02)03571-0 · DOI
- Hama, 2001, Clearance of extracellular and cell-associated amyloid beta peptide through viral expression of neprilysin in primary neurons, J. Biochem. (Tokyo), 130, 721, 10.1093/oxfordjournals.jbchem.a003040 · DOI
- Hellström-Lindahl, 1997, Expression of nicotinic receptor subunits mRNAs in lymphocytes from normal and Alzheimer patients, Alzheimer's Res., 3, 29
- Hellström-Lindahl, 1999, Regional distribution of nicotinic receptor subunit mRNAs in human brain: comparison between Alzheimer and normal brain, Mol. Brain Res., 66, 94, 10.1016/S0169-328X(99)00030-3 · DOI · Paper page
- Hellström-Lindahl, 2004, Nicotine reduces Aβ in the brain and cerebral vessels of APPsw mice, Eur. J. Neurosci., 19, 2703, 10.1111/j.0953-816X.2004.03377.x · DOI
- Hellström-Lindahl, 2004, Reduced levels of Aβ 40 and Aβ 42 in brains of smoking controls and Alzheimer's patients, Neurobiol. Disease, 15, 351, 10.1016/j.nbd.2003.11.024 · DOI
- Higuchi, 2005, Understanding molecular mechanisms of proteolysis in Alzheimer's disease: progress toward therapeutic interventions, Biochim. Biophys. Acta, 1751, 60, 10.1016/j.bbapap.2005.02.013 · DOI
- Huang, 2004, Estrogen regulates neprilysin activity in rat brain, Neurosci. Lett., 367, 85, 10.1016/j.neulet.2004.05.085 · DOI
- Ingelsson, 2004, Early Aβ accumulation and progressive synaptic loss, gliosis, and tangle formation in AD brain, Neurology, 62, 925, 10.1212/01.WNL.0000115115.98960.37 · DOI · Paper page
- Ishii, 1997, Aβ 1-40 but not Aβ 1-42 levels in cortex correlate with apolipoprotein E ɛ4 allele dosage in sporadic Alzheimer's disease, Brain Res., 748, 250, 10.1016/S0006-8993(96)01363-7 · DOI · Paper page
- Iwata, 2001, Metabolic regulation of brain Aβ by neprilysin, Science, 292, 1550, 10.1126/science.1059946 · DOI · Paper page
- Iwata, 2002, Region-specific reduction of Aβ degrading endopeptidase, neprilysin, in mouse hippocampus upon aging, J. Neurosci. Res., 70, 493, 10.1002/jnr.10390 · DOI · Paper page
- Iwata, 2004, Presynaptic localization of neprilysin contributes to efficient clearance of amyloid-β peptide in mouse brain, J. Neurosci., 24, 991, 10.1523/JNEUROSCI.4792-03.2004 · DOI · Paper page
- Kanemitsu, 2003, Human neprilysin is capable of degrading amyloid b peptide not only in the monomeric form but also the pathological oligomeric form, Neurosci. Lett., 350, 113, 10.1016/S0304-3940(03)00898-X · DOI · Paper page
- Kar, 2004, Interactions between β-amyloid and central cholinergic neurons: implications for Alzheimer's disease, J. Psychiatry Neurosci., 29, 427
- Leissring, 2003, Enhanced proteolysis of β-amyloid in APP transgenic mice prevents plaque formation, secondary pathology, and premature death, Neuron, 40, 1087, 10.1016/S0896-6273(03)00787-6 · DOI · Paper page
- Lue, 1999, Soluble amyloid β peptide concentration as a predictor of synaptic change in Alzheimer's disease, Am. J. Pathol., 155, 853, 10.1016/S0002-9440(10)65184-X · DOI · Paper page
- Marr, 2004, Neprilysin regulates amyloid β peptide levels, J. Mol. Neurosci., 22, 5, 10.1385/JMN:22:1-2:5 · DOI
- Mc Khann, 1984, Clinical diagnosis of Alzheimer's disease: report of NINCDS-ADRDA Work Group under the auspices of department of health and human services task forces on Alzheimer's disease, Neurology, 34, 939, 10.1212/WNL.34.7.939 · DOI · Paper page
- Mohajeri, 2002, Aβ 42-induced increase in neprilyin is associated with prevention of amyloid plaque formation in vivo, J. Biol. Chem., 277, 35460, 10.1074/jbc.M202899200 · DOI
- Mohajeri, 2004, Anti-amyloid activity of neprilysin in plaque-bearing mouse models of Alzheimer's disease, FEBS Lett., 562, 16, 10.1016/S0014-5793(04)00169-3 · DOI
- Mousavi, 2003, Protein and mRNA level of nicotinic receptors in brain of tobacco using controls and patients with Alzheimer's disease, Neuroscience, 122, 515, 10.1016/S0306-4522(03)00460-3 · DOI
- Hellström-Lindahl, 2002, Chronic nicotinic treatment reduces B-amyloidosis in the brain of a mouse model of Alzheimer's disease (APPSWE), J. Neurochem., 81, 655, 10.1046/j.1471-4159.2002.00874.x · DOI · Paper page
- Pardossi-Piquard, 2005, Presenilin-dependent transcriptional control of the Aβ-degrading enzyme neprilysin by intracellular domains of β APP and APLP, Neuron, 46, 541, 10.1016/j.neuron.2005.04.008 · DOI · Paper page
- Pardossi-Piquard, 2006, Neprilysin activity and expression are controlled by nicastrin, J. Neurochem., 97, 1052, 10.1111/j.1471-4159.2006.03822.x · DOI
- Parvathy, 2001, Correlation between Aβx-40-, Aβx-42-, and Aβx-43-containing amyloid plaques and cognitive decline, Arch. Neurol., 58, 2025, 10.1001/archneur.58.12.2025 · DOI
- Petanceska, 2000, Ovariectomy and 17β-estradiol modulate the levels of Alzheimer's amyloid β peptides in brain, Exp. Gerontol., 35, 1317, 10.1016/S0531-5565(00)00157-1 · DOI
- Piccini, 2005, β-Amyloid is different in normal aging and in Alzheimer's disease, J. Biol. Chem., 280, 34186, 10.1074/jbc.M501694200 · DOI · Paper page
- Price, 1999, Tangles and plaques in nondemented aging and “preclinical” Alzheimer's disease, Ann. Neurol., 45, 358, 10.1002/1531-8249(199903)45:3<358::AID-ANA12>3.0.CO;2-X · doi:10.1002/1531-8249(199903)45:3<358::aid-ana12>3.0.co;2-x
- Qui, 1997, Degradation of amyloid beta-protein by a metalloprotease secreted by microglia and other non-neuronal cells, J. Biol. Chem., 272, 6641, 10.1074/jbc.272.10.6641 · DOI · Paper page
- Reisberg, 1982, The global deterioration scale for assessment of primary degenerative dementia, Am. J. Psychol., 139, 1136, 10.1176/ajp.139.9.1136 · DOI · Paper page
- Roques, 1993, Neutral endopeptidase 24.11: structure, inhibition, and experimental and clinical pharmacolgy, Pharmacol. Rev., 45, 87
- Russo, 2005, Neprilysin decreases uniformly in Alzheimer's disease and in normal aging, FEBS, 579, 6027, 10.1016/j.febslet.2005.09.054 · DOI
- Saito, 2005, Somatostatin regulates brain amylod B peptide Aβ 42 through modulation of proteolytic degradation, Nat. Med., 11, 434, 10.1038/nm1206 · DOI · Paper page
- Selkoe, 2001, Alzheimer's disease: genes, proteins, and therapy, Physiol. Rev., 81, 741, 10.1152/physrev.2001.81.2.741 · DOI · Paper page
- Selkoe, 2003, Alzheimer's disease: molecular understanding predicts amyloid-based therapeutics, Ann. Rev. Pharmacol. Toxicol., 43, 545, 10.1146/annurev.pharmtox.43.100901.140248 · DOI · Paper page
- Turner, 2001, The neprilysin (NEP) family of zinc metalloendopeptidases: genomics and function, Bioessays, 23, 261, 10.1002/1521-1878(200103)23:3<261::AID-BIES1036>3.0.CO;2-K · DOI · Paper page
- Vardy, 2005, Proteolytic mechanism in amyloid-β metabolism: therapeutic implications for Alzheimer's disease, Trends Mol. Med., 1, 462
- Walker, 2000, Apolipoprotein E4 promotes the early deposition of Aβ 42 and the Aβ40 in the elderly, Acta Neuropathol., 100, 36, 10.1007/s004010051190 · DOI
- Wang, 2003, Oxidized neprilysin in aging and Alzheimer's disease, Biochem. Biophys. Res. Commun., 310, 236, 10.1016/j.bbrc.2003.09.003 · DOI
- Wang, 2005, Decreased neprilysin immunoreactivity in Alzheimer disease, but not in pathological aging, J. Neuropathol. Exp. Neurol., 64, 378, 10.1093/jnen/64.5.378 · DOI
- Yasojima, 2001, Reduced neprilysin in high plaque areas of Alzheimer brain: a possible relationship to deficient degradation of β-amyloid peptide, Neurosci. Lett., 297, 97, 10.1016/S0304-3940(00)01675-X · DOI · Paper page
- Yasojima, 2001, Relationship between amyloid peptide generating molecules and neprilysin in Alzheimer disease and normal brain, Brain Res., 919, 115, 10.1016/S0006-8993(01)03008-6 · DOI · Paper page
- Zhu, 2005, Oxidative imbalance in Alzheimer's disease, Mol. Neurobiol., 31, 205, 10.1385/MN:31:1-3:205 · DOI
Cited by
The Amyloid Beta Peptide: A Chemist’s Perspective. Role in Alzheimer’s and Fibrillization
Hamley, I. W. (2012) · Chemical Reviews · doi:10.1021/cr3000994 · Cited by 882
APP mouse models for Alzheimer’s disease preclinical studies.
Sasaguri, H., Nilsson, P., Hashimoto, S., Nagata, K., Saito, T., De Strooper, B., Hardy, J., Vassar, R., Winblad, B., & Saido, T. C. (2017) · The EMBO Journal · doi:10.15252/embj.201797397 · Cited by 793
Epigenetic mechanisms in neurological diseases: genes, syndromes, and therapies
Urdinguio, R. G., Sanchez-Mut, J. V., & Esteller, M. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70262-5 · Cited by 582
Inflammation: the link between comorbidities, genetics, and Alzheimer’s disease
Newcombe, E. A., Camats-Perna, J., Silva, M. L., Valmas, N., Huat, T. J., & Medeiros, R. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1313-3 · Cited by 532
Metal Toxicity Links to Alzheimer's Disease and Neuroinflammation
Huat, T. J., Camats-Perna, J., Newcombe, E. A., Valmas, N., Kitazawa, M., & Medeiros, R. (2019) · Journal of Molecular Biology · doi:10.1016/j.jmb.2019.01.018 · Cited by 470
Metadata
- Authors
- Hellström-Lindahl, E., Ravid, R., & Nordberg, A.
- Venue
- Neurobiology of Aging
- Publisher
- Elsevier BV
- Published
- 2008-02
- Volume
- 29
- Issue
- 2
- Pages
- 210-221
- ISSN
- 0197-4580 (ISSN-L)
- OpenAlex
- W2073364218
- Cited by
- 165
- References
- 13
- FWCI
- 5.10
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Age-dependent decline of neprilysin in Alzheimer's disease and normal brain: Inverse correlation with Aβ levels. https://app.cochat.ai/papers/10.1016/j.neurobiolaging.2006.10.010
- The paper
- Hellström-Lindahl, E., Ravid, R., & Nordberg, A. (2008). Age-dependent decline of neprilysin in Alzheimer's disease and normal brain: Inverse correlation with Aβ levels. Neurobiology of Aging. https://doi.org/10.1016/j.neurobiolaging.2006.10.010
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.